It may be of interest that psychological tests in one of the patients showed improvement during continuous oral medication with 4-AP, but no systematic examination of effects on mental functions was performed. Considering the strong cholinergic activity of 4-AP and the low concentration of choline acetyltransferase found in dementia,20 we suggest that the drug should be tried in different types of dementia, perhaps in combination with the acetylcholine precursor choline. We also tried 4-AP treatment in a 52-year-old male with oromandibular dystonia (Meige's or Brueghel's syndrome)21 without effect on the involuntary movements in that disease. 
